Shop Apotheke Europe NV (SAEG)

  • Volume:
  • Bid/Ask:
  • Day's Range:
    131.000 - 135.900
  • Type:Equity
  • Market:Germany
  • ISIN:NL0012044747
  • WKN:A2AR94

SAEG Comments

What is your sentiment on Shop Apotheke Europe NV?
Market is currently closed. Voting is open during market hours.

All Comments

  • .....and In his latest research note, analyst Gerhard Orgonas confirms his positive recommendation. The broker Berenberg is keeping its Buy rating. The target price is reduced from EUR 230 to EUR 215.
    • why reduced?
    • are you sure please ?
  • the title will just have to go up, PRESS RELEASE : SHOP APOTHEKE EUROPE Growth in Q2 temporarily decelerated to 7.3%, but Preliminary sales grew by 14.9% during the first six months of 2021.
    • Great title! Despite the decline in recent periods, according to Warburg Research analyst Michael Heider, he continues to maintain his recommendation on the stock with a Neutral rating. The target price continues to be set at 179 euros. marketscreener. com / quote / stock / SHOP-APOTHEKE-EUROPE-N-V-31620967 / news / SHOP-APOTHEKE-EUROPE-NV-nbsp-Warburg-Research-sticks-Neutral-35805419 /
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.